The FDA has approved Sephience for the treatment of HPA in adult and pediatric patients 1 month of age and older with sepiapterin-responsive PKU.

The presence of excess weight or obesity in long COVID is significantly associated with neurological and neuropsychiatric symptom development.

HealthDay News — Intranasal administration of [ 68 Ga]Ga-NOTA-insulin is safe and delivers insulin to multiple brain regions, according to a study published online July 23 in Alzheimer’s & Dementia: ...

(HealthDay News) — Women with multiple sclerosis (MS) are less likely to receive disease-modifying therapies (DMTs) than men, according to a study published online July 30 in Neurology.

Individuals with social risk factors at the time of SARS-CoV-2 infection have increased risk for subsequent long COVID.

Adolescents who use tobacco products are significantly more likely to report symptoms of depression and anxiety than teens who do not use tobacco products.

Among patients with T2D and DPN, some with nonpainful DPN developed neuropathic pain over a 5-year period while others with painful DPN experienced relief.

Lifetime risk for dementia is higher among women, Black adults, and APOE ε4 allele carriers, with the number of new cases expected to rise over the next 4 decades.

Neuroanatomical variability is associated with early substance use initiation, according to a cohort study published in JAMA Network Open.

The Food and Drug Administration has granted Fast Track designation to PMN310 for the treatment of Alzheimer disease.

Only 36.8 percent of adolescents diagnosed with cannabis use disorder (CUD) complete treatment, according to a study published online July 22 in Pediatric Repor ...

Screening for emotional and cognitive issues after ischemic stroke does not improve societal participation at 1 year.